Trial Profile
Efficacy and Safety of SK-0403 in Patients with Type 2 Diabetes
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 14 Mar 2018
Price :
$35
*
At a glance
- Drugs Anagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- Sponsors Sanwa Kagaku Kenkyusho
- 25 May 2016 New trial record